Financhill
Sell
44

RYTM Quote, Financials, Valuation and Earnings

Last price:
$59.98
Seasonality move :
-17.84%
Day range:
$55.85 - $57.14
52-week range:
$35.17 - $68.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.05x
P/B ratio:
306.76x
Volume:
367K
Avg. volume:
533.9K
1-year change:
21.78%
Market cap:
$3.4B
Revenue:
$77.4M
EPS (TTM):
-$4.33

Earnings Data

Next earnings date for RYTM
Feb 21
2025
Most recent earnings per share
-$0.73
Beat by $0.14
(Nov 5/2024)
Consensus Estimate
-$0.87
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RYTM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $38.1M -- -- -$0.76 --
02/21/2025 Q4 $36M -- -- -$0.80 --
11/05/2024 Q3 $32.5M $33.3M -$0.73 -$0.87 $0.14
08/06/2024 Q2 $28.8M $29.1M -$0.55 -$0.72 $0.17
05/07/2024 Q1 $26.9M $26M -$2.35 -$2.39 $0.04
02/22/2024 Q4 $25.4M $24.2M -$0.70 -$0.71 $0.01
11/07/2023 Q3 -- -- -$0.76 -$0.76 -$0.00
08/01/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/02/2023 Q1 -- -- -$0.92 -$0.77 -$0.15
03/01/2023 Q4 -- -- -$0.75 -$0.78 $0.03
11/08/2022 Q3 -- -- -$0.79 -$0.98 $0.19
08/02/2022 Q2 -- -- -$0.89 -$1.03 $0.14
05/03/2022 Q1 -- -- -$1.05 -$1.04 -$0.01
03/01/2022 Q4 -- -- -$0.85 -$0.93 $0.08
11/02/2021 Q3 -- -- -$0.70 -$0.83 $0.13
08/03/2021 Q2 -- -- -$0.70 -$0.74 $0.04
05/03/2021 Q1 -- -- $0.90 -$0.70 $1.60
03/01/2021 Q4 -- -- -$0.79 -$0.79 --
11/02/2020 Q3 -- -- -$0.77 -$0.80 $0.03
08/03/2020 Q2 -- -- -$0.71 -$0.82 $0.11
05/04/2020 Q1 -- -- -$0.78 -$0.82 $0.04
03/02/2020 Q4 -- -- -$0.78 -$0.92 $0.14
11/01/2019 Q3 -- -- -$1.04 -$1.10 $0.06
07/29/2019 Q2 -- -- -$1.24 -$0.85 -$0.39
05/03/2019 Q1 -- -- -$0.84 -$0.73 -$0.11
03/08/2019 Q4 -- -- -$0.74 -$0.66 -$0.08
11/09/2018 Q3 -- -- -$0.52 -$0.61 $0.09
08/08/2018 Q2 -- -- -$0.52 -$0.47 -$0.05
05/14/2018 Q1 -- -- -$0.60 -- --
03/12/2018 Q4 -- -- -$0.41 -$0.55 $0.14
11/14/2017 Q3 -- -- -$0.66 -$0.56 -$0.11

Rhythm Pharmaceuticals Earnings Questions

  • How Much did Rhythm Pharmaceuticals Generate in Revenue Last Quarter?

    Rhythm Pharmaceuticals reported $33.3M worth of top line sales in its most recent quarter.

  • Did Rhythm Pharmaceuticals Beat Earnings Last Quarter?

    Rhythm Pharmaceuticals announced earnings per share of -$0.73 which represents a beat of analyst forecast a -$0.87 per share.

  • Is Rhythm Pharmaceuticals Profitable?

    Rhythm Pharmaceuticals reported $29.4M that represents $0.48 per share over the last quarter.

  • What is the Analyst Consensus for Rhythm Pharmaceuticals EPS Next Year?

    Rhythm Pharmaceuticals's earnings are forecast to decrease from -$3.20 per share to -$4.41 per share next year representing a decrease of -37.93%.

  • When is Rhythm Pharmaceuticals's Earnings Date?

    Rhythm Pharmaceuticals's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Broadcom vs American Express: Which Is Best?
Broadcom vs American Express: Which Is Best?

Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…

Why Is Adobe Stock Dropping?
Why Is Adobe Stock Dropping?

Why is Adobe stock dropping? A combination of underwhelming fiscal…

Why Is 3M Stock Going Up?
Why Is 3M Stock Going Up?

After a decade-long slump in new product introductions, the leading…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 41x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Sell
25
DRUG alert for Jan 2

Bright Minds Biosciences [DRUG] is up 13.55% over the past day.

Buy
56
QMCO alert for Jan 2

Quantum [QMCO] is up 0.83% over the past day.

Buy
78
BMA alert for Jan 2

Banco Macro SA [BMA] is up 12.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock